RuZ has a high drug loading rate, and this, in combination with its typical octahedral structure, decreases its interaction with the ABCG2 and ABCB1 transporters, producing an increase in RuZ retention in drug-resistant cancer cells. Here, ABCG2 is linked to cancer.